Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
linear decrease » linear increase (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
linear decrease » linear increase (Expand Search)
-
321
-
322
-
323
Clinical characteristics.
Published 2024“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”
-
324
-
325
-
326
-
327
-
328
-
329
-
330
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025Subjects: -
331
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025Subjects: -
332
Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging
Published 2025Subjects: -
333
Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf
Published 2025“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”
-
334
-
335
Baseline clinical data.
Published 2025“…Correlation analyses indicated that both M1 and M1/M2 were positively correlated with the modified plaque index, modified sulcular bleeding index, and probing depth, suggesting that the M1/M2 ratio reflects the clinical severity of PI. In vitro experiments showed that the addition of Gal-9 led to a significant increase in the proportion of TIM-3<sup>+</sup>M1 and TIM-3<sup>+</sup>M2 macrophages and a decrease in M1 cell proportions and M1/M2 ratio. …”
-
336
Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia...
Published 2025Subjects: “…treatment initiation decreased…”
-
337
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: “…treatment initiation decreased…”
-
338
Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later.
Published 2025Subjects: “…treatment initiation decreased…”
-
339
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: “…treatment initiation decreased…”
-
340
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: “…treatment initiation decreased…”